While most studies examined the role of PD-1/PD-L1 axis inhibition in bolstering radiation efficacy, Wang et al. reported that radiotherapy can reverse tumor resistance towards anti-PD-1 therapy through induction of IFN-β and MHC-I expression on tumor cells [115]. Here, IFNB1 is linked to neoplasm.